Rezolute (NASDAQ:RZLT) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.22, missing the consensus estimate of $-0.17 by $0.05 per share. Revenue came in at , meeting the estimate of .
Rezolute's stock moved following the earnings release. The stock currently trades at $3.71 with a market capitalization of $129.4M.


